Stanford University Licenses Ingenuity Pathways Analysis, Collaborates on Systems Biology Solutions
Stanford Genome Technology Center Will apply Ingenuity's technology to More Quickly and Comprehensively Understand the Biology Underlying Their Experimental Datasets
Ingenuity is pleased to announce today that the Stanford Genome Technology Center at Stanford University has licensed Ingenuity Pathways Analysis, a new web-delivered application that enables biologists to discover, visualize, and explore therapeutically relevant networks significant to their experimental results.
Dr. Ronald Davis, Professor of Biochemistry and Genetics at Stanford University and Director of the Stanford Genome Technology Center, first used the application during its beta release. Dr. Davis, who is pleased with the application's novel analysis of gene expression data said, "Ingenuity Pathways Analysis is the first successful application to bring a systems biology approach to large datasets, enabling functional analysis on a genome scale. Its delivery, incredible ease-of-use, and most importantly, its biological insights, make this a necessary solution for anyone doing gene or protein based research."
In addition to licensing the Ingenuity Pathways Analysis application, Ingenuity and the Stanford Genome Technology Center are collaborating on the development of new functionality to further extend the application's capabilities and the state of the art of systems biology.
Jake Leschly, President and CEO of Ingenuity Systems stated, "We are pleased to be working with Dr. Davis and his team. Together, we will advance the field of systems biology and its practical application to everyday research challenges."
Other news from the department business & finance
Most read news
More news from our other portals
Last viewed contents
Spoiled oranges shine light on malignant cells - Biomedical device passes the litmus test
UT Southwestern researchers determine 3-D atomic structure of cholesterol transporter
Mount Sinai researchers develop tool to determine function of MicroRNAs
PAION agreement with Lundbeck comes into force, securing future Desmoteplase development and EUR 8 million upfront-payment
Epistem's Biomarker Division Gains GCLP Accreditation
Association for Professionals in Infection Control and Epidemiology, Inc. (APIC) - Washington, USA
Hereditary_nonpolyposis_colorectal_cancer
ClinTec’s CEO, Dr Rabinder Buttar wins the Institute of Directors, Director of the Year Award for Glasgow & West of Scotland
Rescue protein gives doomed cells a stay of 'execution'
Weill Cornell, Ithaca researchers use cotton candy to create new bloodflow routes
Discovery of a gene that causes chronic lymphocytic leukemia - CSIC researchers lead a study that shows that more than 82% of patients with this pathology have high levels of the RRAS2 gene.
